HOME >> MEDICINE >> NEWS
Statement from Barbara Alving of NHLBI on guidelines for cardiovascular disease prevention in women

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health endorses the evidence based guidelines for the prevention of cardiovascular disease (CVD) in women released today by the American Heart Association. These guidelines promise to improve and enhance efforts to reduce the terrible burden of cardiovascular disease among women. Although there have been tremendous improvements in the prevention and treatment of CVD, it remains the top killer of women, as well as men, in the United States. Thus, efforts to attack cardiovascular disease through prevention strategies are vitally important.

The guidelines support these efforts by giving health care providers a document that assembles in one place the evidence-based recommendations from the NHLBI and other authoritative scientific sources and new recommendations where appropriate. The document thus provides guidance on the best cardiovascular disease preventive care for women with a broad range of cardiovascular risk.

The American Heart Association guidelines incorporate and support guidelines developed by the National Cholesterol Education Program, the National High Blood Pressure Education Program, and the Obesity Education Initiative, programs administered by the NHLBI.

The document groups women into categories of high, intermediate, and lower risk, allowing physicians and other health care providers to match the intensity of risk intervention to the level of CVD risk.

Recommendations range from lifestyle interventions such as following a heart healthy diet and incorporating physical activity to the use of specific drugs required to treat risk factors for CVD.

But none of these interventions can occur if women do not realize that they are at risk for heart disease. As the new survey released by the American Heart Association shows, women have made gains in their awareness of heart disease. In 2003, 46 percent of women surveyed listed he
'"/>

Contact: NHLBI Communications Office
nhlbinews@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung, and Blood Institute
4-Feb-2004


Page: 1 2

Related medicine news :

1. Statement on the findings of the Womens Health Study
2. Statement: Implantable medical identification chip
3. Statement from Spondylitis Association of America
4. Statement by Dr. Colwell on Nobel Prizes in Science and NSF onnection
5. The CARDIA Study: Statement from Dr. Claude Lenfant, director, National Heart, Lung, and Blood Institute
6. Statement from Dr. Claude Lenfant, director, NHLBI and Dr. Phillip Gorden, director, NIDDK
7. Statement from Claude Lenfant, M.D., NHLBI Director, on Trends in Hypertension
8. Dental Researchers Retract Statement Indicating Hydrogen Peroxide May Be Cancer Promoter
9. NHLBI study shows smoking cessation programs improve survival
10. Frequent fast food meals increase weight, diabetes risk, NHLBI study says
11. NHLBI statement on oral contraceptive study

Post Your Comments:
(Date:5/23/2013)... who eat at fast-food restaurants are consuming significantly more ... worst offenders, a new study found. "Teens underestimate ... much as 34 percent, parents of school-age children by ... much as 20 percent," study lead researcher, Dr. Jason ... Wood Johnson Foundation, which helped fund the study. ...
(Date:5/23/2013)... when a woman harried by hot flashes says she,s ... published online in Menopause , the journal of ... objective tests that what these women say about their ... showed that hot flashes were related to memory problems, ... there was a relationship between hot flashes and what ...
(Date:5/23/2013)... 2013 “Talk. They Hear You.” a ... parents to talk to children as young as nine ... launched today by the Substance Abuse and Mental Health ... conjunction with SAMHSA’s 2013 National Prevention Week—an annual health ... substance abuse and mental health issues. , SAMHSA’s latest ...
(Date:5/23/2013)... May 23, 2013 Live ... contemporary services, provides the best business lead solution ... Its Call center Management solution features Free Web ... Call Limitation, Do-Not-Call Maintenance and "Automatic Transfer Retry". ... comprehensive campaign delivery and management system. , Its ...
(Date:5/23/2013)... be tested in a clinical trial by a biomedical ... disease has failed to work with the same type ... results of a study by University of Florida researchers. ... with the Evelyn F. and William L. McKnight Brain ... of verifying promising research results before investing in clinical ...
Breaking Medicine News(10 mins):Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3
(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...
(Date:5/23/2013)... 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of novel bile acid ... biliary cirrhosis, today announced that Mark Pruzanski ... present at the Deutsche Bank Securities 38th Annual Health ... Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
(Date:5/23/2013)...  Inhibikase Therapeutics, Inc., an emerging leader in ... present new results on its antiviral program to ... the PML Consortium (composed of Pfizer, Bristol-Meyers Squibb, ... the causative agent of Progressive Multifocal Leukoencephalopathy (PML). ... extended release formulation, can clear JC polyomavirus (JCV) ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2
Cached News: